Önder S, Özogul E, Koksal D, Sarinc Ulasli S, Firat P, Emri S. Diagnostic value of BRCA1-associated protein-1, glucose transporter-1 and desmin expression in the discrimination between reactive mesothelial proliferation and malignant mesothelioma in tissues and effusions. Cytopathology. 2019 Nov;30(6):592-600. doi: 10.1111/cyt.12738.
Abbas S, Simsek Ozek N, Emri S, Koksal D, Severcan M, Severcan F. Diagnosis of malignant pleural mesothelioma from pleural fluid by Fourier transform-infrared spectroscopy coupled with chemometrics. J Biomed Opt. 2018 Oct;23(10):1-14. doi: 10.1117/1.JBO.23.10.105003. Erratum in: J Biomed Opt. 2018 Oct;23(10):1.
Emri SA. The Cappadocia mesothelioma epidemic: its influence in Turkey and abroad. Ann Transl Med. 2017 Jun;5(11):239. doi: 10.21037/atm.2017.04.06.
Koksal D, Safak O, Ozcan A, Agackiran Y, Erturk H, Findik G. Thromboembolic Events in Malignant Pleural Mesothelioma. Clin Appl Thromb Hemost. 2016 May;22(4):390-4. doi: 10.1177/1076029614564861. Epub 2014 Dec 18.
Ozmen O, Koyuncu A, Koksal D, Tatci E, Alagoz E, Demirag F, Gokcek A, Arslan N. The potential value of volume-based quantitative PET parameters and increased bone marrow uptake for the prediction of survival in patients with malignant pleural mesothelioma. Nucl Med Commun. 2016 Jan;37(1):43-9. doi: 10.1097/MNM.0000000000000402.
Koyuncu A, Koksal D, Ozmen O, Demirag F, Bayiz H, Aydogdu K, Berkoglu M. Prognostic factors in malignant pleural mesothelioma: a retrospective study of 60 Turkish patients. J Cancer Res Ther. 2015 Jan-Mar;11(1):216-22. doi: 10.4103/0973-1482.138094.
Emri S, Kilickap S, Kadilar C, Halil MG, Akay H, Besler T. Serum levels of alpha-tocopherol, vitamin C, beta-carotene, and retinol in malignant pleural mesothelioma. Asian Pac J Cancer Prev. 2012;13(7):3025-9. doi: 10.7314/apjcp.2012.13.7.3025.
KONGRE BİLDİRİLERİ
Emri S, D. Yonar, A. Sandal, U. Yılmaz, F. Severcan, Differantiation of mesothelioma from lung cancer and healthy individuals using human by ATR-FTIR spectroscopy coupled with chemometrics. IASLC. 2015. 6-9 September-Denver Colarado
Abbas S, Ozek NS, Koksal D, Severcan M, Emri SA, Severcan F. Infrared spectroscopy as a novel approach in differential diagnosis of malignant pleural mesothelioma from lung cancer using pleural fluid. IASLC 16th World Conference on Lung Cancer, 6-9 September, 2015, Denver, Colorado, USA. J Thorac Oncol 2015; 10 (Suppl 2): s350 (MINI24.07).
Dr. Özge Yavuz Sarı, Prof. Dr. Salih Emri. Malignant Pleural Mesothelioma: Current Status and Future Projections in Turkey. European Respiratory Society 2015 International Congress
Onder S, Ozogul E, Koksal D, Ulaslı SS, Emri S. High Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma from Turkey. IASLC 17th World Conference on Lung Cancer, December 4-7, 2016, Vienna, Austria. J Thorac Oncol 2017; 12 (Suppl 1): s1357-8. (P3.03-023).
Emri S, Dikmen G, Ulasli SS, Esendagli D, Yilmaz U, Ozek N, Severcan F (Severcan, Okur, H, Akbiyik F. Diagnostic Utility Of Mesothelin, Osteopontin And Megakaryocyte Potentiation Factor In Turkısh Patients with Malignant Mesothelioma. IASLC 17th World Conference, 2016. J Thorac Oncol. 2017 12:S1377-S1378:P3.03-052
Tekin F, Köksal D, Dikmen ZG, Karahan S, Bayler R, Ancın B, Dikmen E, Akıncı D, Onder S. The role of monocyte chemoattractant protein-1 (MCP-1) in the development of malignant pleural effusion. European Respiratory Society Annual Congress 2021. (Sözlü sunum olarak sunulmuştur)